PUBLISHER: Renub Research | PRODUCT CODE: 1438319
PUBLISHER: Renub Research | PRODUCT CODE: 1438319
Next Generation Sequencing Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Opportunity Company Analysis
Global Next Generation Sequencing (NGS) Market is predicted to be valued at around US$ 34.19 Billion by 2030, according to Renub Research. Next-generation sequencing (NGS) has revolutionized genomics, enabling speedy and excessive-throughput DNA sequencing. This advanced technology allows for parallel sequencing of several DNA fragments, remodeling genomics research, personalized medicinal drugs, and programs throughout biology, medicine, and agriculture. Techniques consisting of Illumina sequencing, which rose in the mid-2000s, have substantially reduced the time and cost of genetic studies, personalized medicine, and diagnostics. NGS's scalability and precision have redefined biology, driving information genetics, evolution, and ailment mechanisms breakthroughs.
Global Next Generation Sequencing (NGS) Market is anticipated to experience a CAGR of 18.16% from 2024 to 2030
The growing adoption of Next-Generation Sequencing (NGS) in scientific prognosis propels the worldwide NGS market expansion. NGS's capacity to offer comprehensive genetic statistics has unexpectedly improved its position in diagnosing various illnesses and assisting in personalized remedy decisions. The growing demand for precision medicinal drugs and improvements in genomic research expand NGS applications, fostering market growth. As NGS becomes necessary for medical workflows, its full use in diagnostics contributes drastically to the non-stop enlargement of the global market.
The market is growing because many companies are replacing outdated technology like microarrays with NGS, which gives superior accuracy, better throughput, and cost-effectiveness compared to standard methods. In 2022, a piece of writing published by Elsevier stated that NGS is advanced compared to microarrays in detecting DNA and appears to have other genomic obligations. As more and more businesses transfer from older technologies to NGS systems for genomic evaluation, the market is experiencing full-size growth. This shift highlights the vital position of NGS in advancing research, diagnostics, and personalized medicinal drugs, driving the continuous development of the next-era sequencing market.
North America and Europe are witnessing fast scientific trends in NGS methodologies for oncology and infectious disease applications. As researchers and healthcare experts seek complete solutions, NGS offerings, including sequencing and data interpretation, have become important. The advent of NGS panels, designed for focused sequencing of particular genomic regions, has revolutionized genetic analysis, imparting cost-effective and efficient solutions for various applications. Advancements in NGS technology and growing cognizance across various sectors make certain a promising future for genomics and precision medicine. Hence, the global next-generation sequencing (NGS) market was US$ 10.63 Billion in 2023.
Reagents and consumables sector accounted for a significant portion of the global next-generation sequencing market
By products, the global next-generation sequencing market is fragmented into Instruments, Reagents & Consumables, and Services. The reagents and consumables phase held one of the most significant shares in the global next-generation sequencing market. This, in particular, is attributed to the recurrent utilization and high demand for reagents and consumables in NGS's commercial and research applications. These consumables encompass sample preparation kits as well as kits for target enrichment. The adoption of NGS reagents and consumables has expanded as most pharmaceutical agencies and research institutes are utilizing NGS for several diagnostic programs and cancer studies.
Diagnostic application is one of the most critical segments in the global next-generation sequencing market
By application, the global next-generation sequencing market is segmented into Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others. Diagnostic applications are pivotal in the global Next-Generation Sequencing (NGS) market. This is due to their direct effect on healthcare. NGS's capability to research genetic versions enables precise disease prognosis, diagnosis, and personalized remedy selection. This section addresses important wishes in oncology, uncommon diseases, infectious illnesses, and prenatal screening, driving market increase. As healthcare structures prioritize precision medicine and genomic-pushed tactics, diagnostic applications become a cornerstone, contributing notably to the prominence and expansion of the global NGS market.
Sequencing by synthesis is one of the top technologies in the global market for next-generation sequencing
By technology, the global next-generation sequencing market is categorized into Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others. Sequencing by synthesis (SBS) is one of the most famous technologies in the global Next-Generation Sequencing (NGS) market. This technology permits immediate and correct sequencing by constructing complementary DNA strands step by step. Its significant use is pushed through its capability to utilize vast quantities of data, produce low mistake rates, and be cost-effective, making it ideal for various programs in studies, diagnostics, and customized medicine. As the desire for big-scale genomic evaluation continues to develop, SBS will remain an important technology, expanding the worldwide NGS market in the coming years.
Academic and clinical research centers are expected to be one of the fastest-growing segments in the global market
The end-users classify the global next-generation sequencing market into Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others. The academic and clinical research facilities segment is anticipated to be one of the quickest-growing segments within the market. This is due to the increasing use of next-generation sequencing (NGS) in cancer research. This technology enables the identification of new cancer-related genes, the examination of tumor heterogeneity, and the detection of alterations contributing to tumorigenesis. Also, providing scientific studies through market entities is predicted to offer ample opportunities for enhancing and detecting goals in this area.
United States will lead the global Next-Generation Sequencing (NGS) market
By countries, the global next-generation sequencing market is organized into North America (United States, Canada), Europe, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), Latin America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, United Arab Emirates). The global Next-Generation Sequencing (NGS) market is expected to be led by the United States. This is due to the country's advanced healthcare infrastructure, robust research capabilities, and significant investments in genomics. The US has created a favorable environment for NGS adoption, supported by extensive funding, a solid regulatory framework, and a thriving biotechnology industry. Predicine, Inc. announced in September 2022 regarding the PredicineCARETMcfDNA Assay. This is an NGS assay used for tumor mutation profiling in cfDNA. The cfDNA is isolated from liquid biopsy samples taken from cancer patients. The US FDA has granted this assay breakthrough device designation. This ensures its prominent role and leadership in the global NGS market.
Key Players
Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN N.V., Roche, Bio-Rad Laboratories, Inc., Takara Bio Inc., Hamilton Company, Geneious, and BioMerieux SA are the major companies in the global next-generation sequencing (NGS) market.
In December 2023 - Illumina inscribed a memorandum of understanding with the African Society for Laboratory Medicine to improve access to genomics within the African region to combat infectious diseases.
In March 2023 - The company SOPHiA GENETICS partnered with Qiagen to use QIAseq reagent technology with the DDM platform to improve tumor analysis using next-generation sequencing (NGS).
Renub Research report titled "Global Next-Generation Sequencing (NGS) Market By Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others),Countries (North America (United States, Canada), Europe, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand), Latin America (Brazil, Mexico, Argentina), Middle East & Africa (Saudi Arabia, United Arab Emirates, South Africa)) Company Analysis (Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN N.V., Roche, Bio-Rad Laboratories, Inc., Takara Bio Inc., Hamilton Company, Geneious, and BioMerieux SA)" provides a complete study of the Global Next-Generation Sequencing (NGS) Industry.
Product - Global Next-Generation Sequencing (NGS) Market breakup in 3 viewpoints:
1. Instruments
2. Reagents & Consumables
3. Services
Application - Global Next-Generation Sequencing (NGS) Market breakup in 5 viewpoints:
1. Diagnostics
2. Agriculture and Animal Research
3. Drug Discovery
4. Personalized Medicine and Genetic Screening
5. Others
Technology - Global Next-Generation Sequencing (NGS)Market breakup in 5 viewpoints:
1. Sequencing by Synthesis
2. Ion Semiconductor Sequencing
3. Single-Molecule Read Time Sequencing
4. Nanopore Sequencing
5. Others
End-Users - Global Next-Generation Sequencing (NGS) Market breakup in 4 viewpoints:
1. Academic and Clinical Research Centers
2. Pharmaceutical and Biotechnology Companies
3. Hospitals and Clinics
4. Others
Countries - Global Next-Generation Sequencing (NGS) Market of 25 Countries:
1 North America
- 1.1 United States
- 1.2 Canada
2 Europe
- 2.1 France
- 2.2 Germany
- 2.3 Italy
- 2.4 Spain
- 2.5 United Kingdom
- 2.6 Belgium
- 2.7 Netherlands
- 2.8 Turkey
3 Asia Pacific
- 3.1 China
- 3.2 Japan
- 3.3 India
- 3.4 South Korea
- 3.5 Thailand
- 3.6 Malaysia
- 3.7 Indonesia
- 3.8 Australia
- 3.9 New Zealand
4 Latin America
- 4.1 Brazil
- 4.2 Mexico
- 4.3 Argentina
5 Middle East & Africa
- 5.1 Saudi Arabia
- 5.2 United Arab Emirates
- 5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. Illumina
2. Thermo Fisher Scientific
3. Pacific Biosciences
4. QIAGEN N.V.
5. Roche
6. Bio-Rad Laboratories, Inc.
7. Takara Bio Inc.
8. Hamilton Company
9. Geneious
10. BioMerieux SA
Table of Contents
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
5. Global Next Generation Sequencing Market
6. Market Share - Global Next Generation Sequencing Market
- 6.1 By Product
- 6.2 By Application
- 6.3 By Technology
- 6.4 By End User
- 6.5 By Countries
7. Product - Global Next Generation Sequencing Market
- 7.1 Instruments
- 7.2 Reagents & Consumables
- 7.3 Services
8. Application - Global Next Generation Sequencing Market
- 8.1 Diagnostics
- 8.2 Agriculture and Animal Research
- 8.3 Drug Discovery
- 8.4 Personalized Medicine and Genetic Screening
- 8.5 Others
9. Technology - Global Next Generation Sequencing Market
- 9.1 Sequencing by Synthesis
- 9.2 Ion Semiconductor Sequencing
- 9.3 Single Molecule Read Time Sequencing
- 9.4 Nanopore Sequencing
- 9.5 Others
10. End User - Global Next Generation Sequencing Market
- 10.1 Academic and Clinical Research Centers
- 10.2 Pharmaceutical and Biotechnology Companies
- 10.3 Hospitals and Clinics
- 10.4 Others
11. Countries - Global Next Generation Sequencing Market
- 11.1 North America
- 11.1.1 United States
- 11.1.2 Canada
- 11.2 Europe
- 11.2.1 France
- 11.2.2 Germany
- 11.2.3 Italy
- 11.2.4 Spain
- 11.2.5 United Kingdom
- 11.2.6 Belgium
- 11.2.7 Netherlands
- 11.2.8 Turkey
- 11.3 Asia Pacific
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 South Korea
- 11.3.5 Thailand
- 11.3.6 Malaysia
- 11.3.7 Indonesia
- 11.3.8 Australia
- 11.3.9 New Zealand
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.2 Mexico
- 11.4.3 Argentina
- 11.5 Middle East & Africa
- 11.5.1 Saudi Arabia
- 11.5.2 United Arab Emirates
- 11.5.3 South Africa
12. Porter's Five Forces Analysis - Global Next Generation Sequencing Market
- 12.1 Threat of New Entry
- 12.2 The Bargaining Power of Buyer
- 12.3 Threat of Substitution
- 12.4 The Bargaining Power of Supplier
- 12.5 Competitive Rivalry
13. SWOT Analysis - Global Next Generation Sequencing Market
- 13.1 Strengths
- 13.2 Weaknesses
- 13.3 Opportunities
- 13.4 Threats
14. Key Players Analysis
- 14.1 Illumina
- 14.1.1 Overview
- 14.1.2 Recent Development
- 14.1.3 Revenue
- 14.2 Thermo Fisher Scientific
- 14.2.1 Overview
- 14.2.2 Recent Development
- 14.2.3 Revenue
- 14.3 Pacific Biosciences
- 14.3.1 Overview
- 14.3.2 Recent Development
- 14.3.3 Revenue
- 14.4 QIAGEN N.V
- 14.4.1 Overview
- 14.4.2 Recent Development
- 14.4.3 Revenue
- 14.5 Roche
- 14.5.1 Overview
- 14.5.2 Recent Development
- 14.5.3 Revenue
- 14.6 Bio-Rad Laboratories, Inc.
- 14.6.1 Overview
- 14.6.2 Recent Development
- 14.6.3 Revenue
- 14.7 Takara Bio Inc
- 14.7.1 Overview
- 14.7.2 Recent Development
- 14.7.3 Revenue
- 14.8 Hamilton Company
- 14.8.1 Overview
- 14.8.2 Recent Development
- 14.8.3 Revenue
- 14.9 Geneious
- 14.9.1 Overview
- 14.9.2 Recent Development
- 14.9.3 Revenue
- 14.10 BioMerieux SA
- 14.10.1 Overview
- 14.10.2 Recent Development
- 14.10.3 Revenue
List of Figures
- Figure-01: Global - Next Generation Sequencing Market (Billion US$), 2019 - 2023
- Figure-02: Global - Forecast for Next Generation Sequencing Market (Billion US$), 2024 - 2030
- Figure-03: Product - Instruments Market (Million US$), 2019 - 2023
- Figure-04: Product - Forecast for Instruments Market (Million US$), 2024 - 2030
- Figure-05: Product - Reagents & Consumables Market (Million US$), 2019 - 2023
- Figure-06: Product - Forecast for Reagents & Consumables Market (Million US$), 2024 - 2030
- Figure-07: Product - Services Market (Million US$), 2019 - 2023
- Figure-08: Product - Forecast for Services Market (Million US$), 2024 - 2030
- Figure-09: Application - Diagnostics Market (Million US$), 2019 - 2023
- Figure-10: Application - Forecast for Diagnostics Market (Million US$), 2024 - 2030
- Figure-11: Application - Agriculture and Animal Research Market (Million US$), 2019 - 2023
- Figure-12: Application - Forecast for Agriculture and Animal Research Market (Million US$), 2024 - 2030
- Figure-13: Application - Drug Discovery Market (Million US$), 2019 - 2023
- Figure-14: Application - Forecast for Drug Discovery Market (Million US$), 2024 - 2030
- Figure-15: Application - Personalized Medicine and Genetic Screening Market (Million US$), 2019 - 2023
- Figure-16: Application - Forecast for Personalized Medicine and Genetic Screening Market (Million US$), 2024 - 2030
- Figure-17: Application - Others Market (Million US$), 2019 - 2023
- Figure-18: Application - Forecast for Others Market (Million US$), 2024 - 2030
- Figure-19: Technology - Sequencing by Synthesis Market (Million US$), 2019 - 2023
- Figure-20: Technology - Forecast for Sequencing by Synthesis Market (Million US$), 2024 - 2030
- Figure-21: Technology - Ion Semiconductor Sequencing Market (Million US$), 2019 - 2023
- Figure-22: Technology - Forecast for Ion Semiconductor Sequencing Market (Million US$), 2024 - 2030
- Figure-23: Technology - Single Molecule Read Time Sequencing Market (Million US$), 2019 - 2023
- Figure-24: Technology - Forecast for Single Molecule Read Time Sequencing Market (Million US$), 2024 - 2030
- Figure-25: Technology - Nanopore Sequencing Market (Million US$), 2019 - 2023
- Figure-26: Technology - Forecast for Nanopore Sequencing Market (Million US$), 2024 - 2030
- Figure-27: Technology - Others Market (Million US$), 2019 - 2023
- Figure-28: Technology - Forecast for Others Market (Million US$), 2024 - 2030
- Figure-29: End User - Academic and Clinical Research Centers Market (Million US$), 2019 - 2023
- Figure-30: End User - Forecast for Academic and Clinical Research Centers Market (Million US$), 2024 - 2030
- Figure-31: End User - Pharmaceutical and Biotechnology Companies Market (Million US$), 2019 - 2023
- Figure-32: End User - Forecast for Pharmaceutical and Biotechnology Companies Market (Million US$), 2024 - 2030
- Figure-33: End User - Hospitals and Clinics Market (Million US$), 2019 - 2023
- Figure-34: End User - Forecast for Hospitals and Clinics Market (Million US$), 2024 - 2030
- Figure-35: End User - Others Market (Million US$), 2019 - 2023
- Figure-36: End User - Forecast for Others Market (Million US$), 2024 - 2030
- Figure-37: United States - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-38: United States - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-39: Canada - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-40: Canada - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-41: France - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-42: France - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-43: Germany - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-44: Germany - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-45: Italy - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-46: Italy - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-47: Spain - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-48: Spain - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-49: United Kingdom - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-50: United Kingdom - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-51: Belgium - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-52: Belgium - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-53: Netherlands - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-54: Netherlands - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-55: Turkey - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-56: Turkey - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-57: China - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-58: China - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-59: Japan - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-60: Japan - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-61: India - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-62: India - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-63: South Korea - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-64: South Korea - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-65: Thailand - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-66: Thailand - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-67: Malaysia - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-68: Malaysia - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-69: Indonesia - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-70: Indonesia - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-71: Australia - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-72: Australia - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-73: New Zealand - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-74: New Zealand - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-75: Brazil - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-76: Brazil - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-77: Mexico - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-78: Mexico - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-79: Argentina - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-80: Argentina - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-81: Saudi Arabia - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-82: Saudi Arabia - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-83: United Arab Emirates - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-84: United Arab Emirates - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-85: South Africa - Next Generation Sequencing Market (Million US$), 2019 - 2023
- Figure-86: South Africa - Forecast for Next Generation Sequencing Market (Million US$), 2024 - 2030
- Figure-87: Illumina - Global Revenue (Million US$), 2019 - 2023
- Figure-88: Illumina - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-89: Thermo Fisher Scientific - Global Revenue (Million US$), 2019 - 2023
- Figure-90: Thermo Fisher Scientific - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-91: Pacific Biosciences - Global Revenue (Million US$), 2019 - 2023
- Figure-92: Pacific Biosciences - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-93: QIAGEN N.V - Global Revenue (Million US$), 2019 - 2023
- Figure-94: QIAGEN N.V - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-95: Roche - Global Revenue (Million US$), 2019 - 2023
- Figure-96: Roche - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-97: Bio-Rad Laboratories, Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-98: Bio-Rad Laboratories, Inc. - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-99: Takara Bio Inc - Global Revenue (Million US$), 2019 - 2023
- Figure-100: Takara Bio Inc - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-101: Hamilton Company - Global Revenue (Million US$), 2019 - 2023
- Figure-102: Hamilton Company - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-103: Geneious - Global Revenue (Million US$), 2019 - 2023
- Figure-104: Geneious - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-105: BioMerieux SA - Global Revenue (Million US$), 2019 - 2023
- Figure-106: BioMerieux SA - Forecast for Global Revenue (Million US$), 2024 - 2030
List of Tables
- Table-01: Global - Next Generation Sequencing Market Share by Product (Percent), 2019 - 2023
- Table-02: Global - Forecast for Next Generation Sequencing Market Share by Product (Percent), 2024 - 2030
- Table-03: Global - Next Generation Sequencing Market Share by Application (Percent), 2019 - 2023
- Table-04: Global - Forecast for Next Generation Sequencing Market Share by Application (Percent), 2024 - 2030
- Table-05: Global - Next Generation Sequencing Market Share by Technology (Percent), 2019 - 2023
- Table-06: Global - Forecast for Next Generation Sequencing Market Share by Technology (Percent), 2024 - 2030
- Table-07: Global - Next Generation Sequencing Market Share by End User (Percent), 2019 - 2023
- Table-08: Global - Forecast for Next Generation Sequencing Market Share by End User (Percent), 2024 - 2030
- Table-09: Global - Next Generation Sequencing Market Share by Countries (Percent), 2019 - 2023
- Table-10: Global - Forecast for Next Generation Sequencing Market Share by Countries (Percent), 2024 - 2030
